Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06506279 · ClinicalTrials.gov registry record · NA
Motor Recovery Through Plasticity-Inducing Cortical Stimulation
A NA study of Stroke, Ischemic, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT06506279: Recruiting NA study of Stroke, Ischemic, sponsored by University of Washington.
NCT06506279 is a NA study of Stroke, Ischemic that is actively recruiting participants, run by University of Washington. The registered enrollment target is 4 participants, below the 290-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06506279, a NA study of Stroke, Ischemic, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
Using the CorTec Brain Interchange (BIC) System, we will examine the effect of a plasticity-inducing therapy regime on the rehabilitation of upper limb impairment post-stroke. This study's main objective is to implement and evaluate neuroplasticity-inducing stimulation. The stimulation methods for inducing neuroplasticity have been selected based on prior preclinical and intraoperative work that has shown promise in providing rehabilitative benefits for stroke patients. We will be structuring this study as an open prospective feasibility study.
Primary Outcome
The primary outcome measure in the study focus on measuring upper limb impairment to ensure that the use of the CorTec Brain Interchange system is not detrimental for use in studying stimulation paradigms to improve stroke rehabilitation. Limb impairment will be assessed for all patients weekly during the rehabilitation period and at all monthly post-rehab monitoring visits using the primary behavioral measures of the study, UEFM (Upper Extremity Fuegl-Myer) arm motor score and the WMFT (Wolf Mo
Conditions Studied
Interventions
- DEVICE CorTec Brain Interchange (BIC) System
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2030-06-15 |
| Phase | NA |
What NCT06506279 shows while recruiting
NCT06506279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 290-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stroke, Ischemic appearing as the primary indexed condition, and to 1 intervention - of which CorTec Brain Interchange (BIC) System is the first listed.
NCT06506279 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06506279 about?
NCT06506279 is a clinical study titled "Motor Recovery Through Plasticity-Inducing Cortical Stimulation". Using the CorTec Brain Interchange (BIC) System, we will examine the effect of a plasticity-inducing therapy regime on the rehabilitation of upper limb impairment post-stroke. This study's main objective is to implement and evaluate neuroplasticity-inducing stimulation. The stimulation methods for i...
What is the current status of trial NCT06506279?
This trial is currently recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2025-05-01. Estimated completion is 2030-06-15.
What conditions does trial NCT06506279 study?
This clinical trial studies the following conditions: Stroke, Ischemic.
What interventions are being tested in trial NCT06506279?
The interventions under investigation include: CorTec Brain Interchange (BIC) System (DEVICE).
Who is sponsoring clinical trial NCT06506279?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06506279 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Ischemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06506279's enrollment target sits among peer trials
4 34th of 33 the lowest of 33 other Stroke, Ischemic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Vision Loss Impact on Navigation in Virtual Reality
RECRUITING · NA
-
Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke
RECRUITING · NA
-
Utility of CC7 Transfer in Stroke Subtypes
RECRUITING · NA
-
Non-invasive Trigeminal and Vagus Nerve Stimulation for Stroke Subjects With Chronic Upper Extremity Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI